Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Meet Our Co-Editor
Volume: 16 Issue: 3
Author(s): Simone Carradori
Affiliation:
Export Options
About this article
Cite this article as:
Carradori Simone , Meet Our Co-Editor, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2017; 16 (3) . https://dx.doi.org/10.2174/187152301603180330094850
DOI https://dx.doi.org/10.2174/187152301603180330094850 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial: New Therapetic Approaches in the Management of Ischemia Reperfusion Injury and Cardiometabolic Diseases: Opportunities and Challenges
Current Drug Targets Gene Therapy and Biologic Therapy with Interleukin?4
Current Gene Therapy Recent Patents in the Field of Radioprotector Development: Opportunities and Challenges
Recent Patents on Biotechnology Controversies in Glaucoma: Current Medical Treatment and Drug Development
Current Pharmaceutical Design Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Oxidative Stress and Endothelial Function: Therapeutic Interventions
Recent Patents on Cardiovascular Drug Discovery Inflammatory Biomarkers for Mood Disorders - A Brief Narrative Review
Current Pharmaceutical Design IO Nation: The Rise of Immuno-Oncology
Current Pharmacogenomics and Personalized Medicine Protective Effect of Ursolic Acid in <i>Prunella vulgaris</i> L. on LPS-Induced Asthenozoospermia via Bcl-2/Bax Apoptosis Signaling Pathway
Current Pharmaceutical Biotechnology Editorial [Hot Topic: Inflammation as Target for Pharmaceutical Intervention in Cancer (Executive Editors: R.M. Schiffelers and K.E. de Visser)]
Current Pharmaceutical Design Editorial from Guest Editor. Chronic Cough
Current Respiratory Medicine Reviews Multidrug Resistance Protein 4 (MRP4/ABCC4): A Suspected Efflux Transporter for Human’s Platelet Activation
Protein & Peptide Letters Production and Immunological Evaluation of Epitope-based Preventative Pneumococcal Candidate Vaccine Comprising Immunodominant Epitopes from PspA, CbpA, PhtD and PiuA Antigens
Current Pharmaceutical Biotechnology Seeds of Mung Bean (<i>Vigna radiata</i> (L.) R.Wilczek): Taxonomy, Phytochemistry, Medicinal Uses and Pharmacology
Current Bioactive Compounds Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Inhibition of Cytochrome P450 1A2-Mediated Metabolism and Production of Reactive Oxygen Species by Heme Oxygenase-1 in Rat Liver Microsomes
Drug Metabolism Letters Aqueous Extracts of Selected Potentilla Species Modulate Biological Activity of Human Normal Colon Cells
Current Drug Targets Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?
Current Vascular Pharmacology Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway
Current Cancer Drug Targets Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell Lymphoma
Current Cancer Drug Targets